Atossa Therapeutics, Inc. (ATOS)
5.93
+0.16
(+2.77%)
USD |
NASDAQ |
Apr 22, 16:00
5.93
0.00 (0.00%)
After-Hours: 20:00
Atossa Therapeutics Cash from Financing (TTM) : 0.00 for Dec. 31, 2025
Cash from Financing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
| Celldex Therapeutics, Inc. | 2.388M |
| Plus Therapeutics, Inc. | 30.31M |
| Abeona Therapeutics, Inc. | 26.04M |
| Cell Source, Inc. | 2.737M |
| Kiora Pharmaceuticals, Inc. | 0.2657M |